Altimmune, Inc. ALT Cash Flow

Altimmune, inc. (ALT)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
-22,308	-20,520	-40,931	-32,342	-38,094	-39,171	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	190,502	193,854	114,814	-5,793	-6,131	-3,440	-4,831	-8,135	-6,233	-9,955	-11,750	-11,068	-11,865	-11,718	-8,563	-4,831	-4,351	-4,920	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Change in value of contingent consideration for acquired in-process research and development
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment charges
-	-	-	-	-	24,940	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation
1,071	1,264	1,054	861	824	773	1,010	1,368	1,455	1,443	1,480	2,534	2,403	2,240	2,082	669	595	613	909	1,096	1,326	1,655	1,578	1,602	1,563	1,362	1,351	1,485	1,674	1,894	0	0	0
Depreciation
238	239	253	263	254	218	168	123	95	83	94	151	118	143	143	97	142	141	145	147	147	149	156	164	169	182	0	0	0	-	-	-	-
Amortization
68	147	173	161	161	83	60	58	57	55	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized losses (gains) on foreign currency exchange
-65	5	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Debt discount accretion
-	-	-	-	-	-	-	-	-	98	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of premium and discount on short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	98	114	129	135	145	152	154	122	0	0	0
Gain from disposal of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	7	7	7	5	5	8	8	3	3	0	0	66	0	0	0
Changes in fair value of warrant liability
-	-	-	-	-	2,878	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in fair value of embedded derivative
-	-	-	-	-	184	0	0	0	-	-	-	-	-	-	-	1	299	621	-298	604	508	1,201	1,133	703	-444	-931	205	676	591	0	0	0
Changes in operating assets and liabilities:
Accounts receivable
-911	-2,440	-1,534	-224	-848	-344	-704	-1,067	2,027	1,948	1,030	2,060	1	-210	665	-81	-5,803	401	0	387	5,973	-1,316	0	-1,540	-1,865	-1,005	-1,606	-1,904	719	-1,991	0	0	0
Prepaid expenses and other current assets
137	-133	-88	93	-308	-499	-391	-718	153	349	105	916	-49	283	313	-177	23	-5	38	-145	80	5	7	352	-63	-282	-122	-474	-269	-367	0	0	0
Accounts payable
914	-354	-100	24	-491	243	-329	-880	-3,814	-2,623	-1,961	-1,344	2,326	405	308	435	-371	129	24	-228	66	-736	-827	-2,552	-817	-569	-737	927	-120	251	0	0	0
Accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued restructuring expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	1,938	0	0	0	0	-	-	-	-	-	-	-	-
Accrued expenses and other current liabilities
1,249	-626	-3,804	-2,238	-1,399	17	0	0	0	-	-	-	-	789	275	-1,142	181	-54	-1,166	395	-584	-2,089	-203	-698	-1,452	773	-669	-1,192	401	-418	0	0	0
Deferred revenue
-14	22	-19	-19	-22	-19	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued income taxes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-341	-415	-508	-812	-1,040	424	489	855	867	0	0	0
Deferred rent
-	-	-	-	-	-	-	-	-	-22	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease obligation
175	175	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unbilled accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	672	665	355	172	-1,055	-1,902	-1,309	-3,077	-2,063	-1,914	-2,068	-1,091	-562	1,093	0	0	0
Tax refund receivable
2,922	-379	-277	-2,760	-5,713	-5,077	-3,576	436	3,897	3,406	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Deferred tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	57	61	59	69	51	61	60	63	81	61	56	49	54	195	0	0	0
Deferred taxes
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of available-for-sale investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-11,836	-9,601	-12,755	-11,351	-7,943	-9,388	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	0	0	0
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sales and maturities of short-term investments
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of short-term investments
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	199,520	201,508	116,815	-6,122	-1,857	-3,215	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Refund of cash held in escrow
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of property and equipment
18	1	8	164	323	975	990	840	725	112	90	102	70	30	48	42	51	86	68	69	90	92	92	93	96	84	84	70	25	0	0	0	0
Proceeds from sale of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	7	7	7	8	8	11	11	3	3	0	0	67	0	0	0
Cash paid for internally developed patents
44	27	26	28	28	40	45	50	51	53	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities
-21,718	-28,286	-28,241	-179	-337	-1,001	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	0	0	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Net cash (used in) provided by investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-66,734	-66,877	-66,895	-90	-51	-78	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of convertible notes, net of issuance costs
-	-	-	-	-	-	-	-	-	3,018	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from stock subscriptions
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	973	3,744	13,242	15,507	18,141	15,291	7,484	8,684	6,018	6,068	3,810	92	38	0	0	0
Proceeds from issuance of common units, net of issuance costs
-	12,668	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock from Employee Stock Purchase Plan
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-750	-1,000	-999	-999	-999	-999	-999	-999	-749	0	0	0	-	-	-	-
Proceeds from issuance of long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Net repayment of revolving credit agreement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-1,091	0	-1,168	-1,329	-238	-1,208	1,168	471	1,330	0	0	0
Deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	108	216	0	0	0
Controlled equity offering issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Change in restricted cash requirements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100	0	0	0
Proceeds from exercises of warrants
0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	-	38	34	16	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-70	12,532	44,005	48,474	45,170	32,489	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	0	0	0
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	0	0	0	0	-	-	-	-	-	-	-	-	-32	0	0	0
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	6,832	3,800	1,801	3,961	411	223	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
-	-	-	-	-	-50	-62	-27	65	74	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase in cash and cash equivalents and restricted cash
-33,625	-25,356	3,008	36,943	36,841	22,049	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EFFECT OF EXCHANGE RATES ON CASH
-	-	-	-	-	-	-	-	-	-	-	-	-	-6	-4	-102	8	-1	-5	-11	-23	-12	-5	1	0	-1	-5	0	-6	0	0	0	0
Net decrease in cash, cash equivalents, and restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,489	-3,073	-2,230	7,146	6,190	8,162	3,676	-4,524	-3,338	-2,220	1,217	4,012	-2,430	1,464	0	0	0
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
-	-	-	-	-	57	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	7	0	0	88	93	108	130	71	99	128	155	182	210	234	259	275	284	220	0	0	0
SUPPLEMENTAL NON-CASH FINANCING ACTIVITIES
Accrued expense capitalized as convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock warrant issued with convertible notes, net of issuance costs
-	-	-	-	-	-	-	-	-	548	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Addition of property and equipment not yet paid
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Addition of intangible assets not yet paid
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease incentive billed but not yet received
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Value of warrants issued to lender in connection with loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Series B Redeemable Convertible Preferred Stock [Member]
Conversion of Series B redeemable convertible preferred stock into common stock
-	-	-	-	-	9,790	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of Series B redeemable convertible preferred stock
-	-	-	-	-	2,894	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-